Cargando…
Appetite for destruction: the inhibition of glycolysis as a therapy for tuberous sclerosis complex-related tumors
The elevated metabolic requirements of cancer cells reflect their rapid growth and proliferation and are met through mutations in oncogenes and tumor suppressor genes that reprogram cellular processes. For example, in tuberous sclerosis complex (TSC)-related tumors, the loss of TSC1/2 function cause...
Autores principales: | Csibi, Alfredo, Blenis, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198763/ https://www.ncbi.nlm.nih.gov/pubmed/22018140 http://dx.doi.org/10.1186/1741-7007-9-69 |
Ejemplares similares
-
Clinical management of tuberous sclerosis complex over the lifetime of a patient
por: Frost, Michael, et al.
Publicado: (2015) -
YAP enters the mTOR pathway to promote tuberous sclerosis complex
por: Liang, Ning, et al.
Publicado: (2015) -
Tubers and Tumors Are CLIPped Together in Tuberous Sclerosis
Complex
por: Dang, Louis
Publicado: (2022) -
Glucose deprivation in tuberous sclerosis complex-related tumors
por: Jiang, Xiuyun, et al.
Publicado: (2011) -
Commentary on “The epileptogenic zone in children with tuberous sclerosis complex is characterized by prominent features of focal cortical dysplasia”
por: Wong, Michael
Publicado: (2022)